home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Key Receptor Identified For HCMV Infection

 
  August, 21 2008 8:20
your information resource in human molecular genetics
 
     

Researchers have identified a critical receptor required for human cytomegalovirus (HCMV) infection. The protein, platelet-derived growth factor-a receptor (PDGFR-a ), may prove a useful target for new anti-viral therapies.

HCMV is a ubiquitous human herpesvirus that can cause life-threatening disease in the fetus and immunocompromised patients. In Nature, Charles Cobbs and colleagues show that HCMV requires PDGFR-a binding and activation for internalization, expression of essential viral genes, production of infectious virus, and activation of key downstream signaling.

If the receptor is knocked out or inactivated, HCMV cannot enter the cell and viral genes are not expressed. The team highlights two compounds - the anti-cancer drug Gleevec and the PDGFR-a -blocking antibody IMC-3G3 - that yield this effect, suggesting that these currently available pharmaceutical agents could prove useful in the treatment of HCMV infection.

CONTACT

Charles Cobbs (University of California San Francisco Medical Center, CA, USA)
E-mail: charles.cobbs@gmail.com

Abstract available online.

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.